Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,891.11
    +563.66 (+1.10%)
     
  • CMC Crypto 200

    1,375.85
    +63.23 (+4.82%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,405.30
    +7.30 (+0.30%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

David Herro Comments on Smiths Group

- By Holly LaFon

We initiated one new position in the quarter and eliminated one holding. Both issues are U.K.-domiciled entities. We sold our holding in Smiths Group (SMIN.L), a conglomerate active in seals (primarily for the oil and gas sector), healthcare, detection and connectors. Smiths' new management team had a strong first year at the helm, highlighted by margin improvement at the detection division, the announced acquisition of Safran's Morpho detection business and a significant de-risking of its U.K. pension plan. We view these developments favorably, as do other investors, and the share price has risen nearly 50% in local currency. However, this increased price more closely reflects our view of the business' intrinsic value and thus we've found more attractive investment alternatives.


From David Herro (Trades, Portfolio)'s Oakmark Global Fund fourth quarter 2016 commentary.
This article first appeared on GuruFocus.